期刊文献+

2型糖尿病合并脂肪肝的危险因素研究 被引量:1

Study on Risk Factors of Type 2 Diabetes Associated with Fatty Liver
下载PDF
导出
摘要 目的:探讨影响糖尿病合并脂肪肝的主要危险因素。方法:采用病例对照研究,2型糖尿病伴有脂肪肝(DFL)组1 1 8例,2型糖尿病不伴脂肪肝(NDFL)组1 4 9例,非糖尿病非酒精性脂肪肝(NDNASH)组5 5例。结果:⑴与DFL有关的危险因素包括体重指数、腰臀比值、血压、空腹胰岛素、餐后2h胰岛素、胆固醇、甘油三酯、HOMA -IR ,其中最主要的两个危险因素是腰臀比值、甘油三酯;⑵DFL组与NDFL组比较,空腹血糖、餐后2h血糖、糖化血红蛋白(HbA1C)无显著差异性;( 3 )NDFL与NDNASH组比较,HOMA -IR差异无显著性。结论:( 1 )影响DFL的因素众多,主要因素是腰臀比值、甘油三酯;( 2 )血糖对DFL发病作用降低;( 3 )脂肪肝可能是糖尿病前一个阶段。 Objective: To explore the risk factors associated with diabetic fatty liver(DFL). Methods: The investigation was conducted by means of case control study,including 118 patients of type 2 diabetes with fatty liver(DFL),149 type 2 diabetes without fatty liver(NDFL),55 nondiabetic nonalcoholic steatohepatitis(NDNASH). Results: ⑴Risk factors related to DFL including BMI,WHR,SBP,DBP,FINS,PINS,TC,TG and HOMA-IR.WHR and TG were the most important of all above variables. ⑵There were not significant differences between DFL and NDFL groups on FBG,P2hBG,HbA_(1C). ⑶There was not significant difference between NDFL and NDNASH groups on HOMA-IR. Conclusion: ⑴The risk factors of DFL includes BMI,WHR,SBP,DBP,FINS,PINS,TC,TG and HOMA-IR. WHR and TG are the most important factors of all. ⑵Effects of plasma glucose on DFL in diabetic patients are decreased. ⑶Fatty liver was probably one prediabetic stage, DFL was probably one of components of matebolic syndrome.
出处 《医学理论与实践》 2005年第4期382-384,共3页 The Journal of Medical Theory and Practice
关键词 脂肪肝 2型糖尿病 胰岛素抵抗 体重指数 甘油三酯 Fatty liver, Type 2 diabetes mellitus, Insulin resistance, Risk factors
  • 相关文献

参考文献9

  • 1Bacon BR,Farahvash MJ,Janney CG,et al. Nonalcoholic steatohepatitis:an expanded clinical entity. Gastroenterology,1994,107:1103-1109.
  • 2Sheth SG,Gordon FD,Chopra S. Nonalcoholic steatohepatitis. Ann Intern Med,1997,126(2):137-145.
  • 3Matthews DR,Hosker JP,Rudenski AS,et al. Homeostasis model assessment:insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia,1985,28(7):412-419.
  • 4Paul A. Nonalcoholic fatty liver disease. N Engl J Med,2002,346(16):1221-1231.
  • 5Cortez PH,Camilo ME,Baptista A,et al. Nonalcoholic fatty liver:another feature of the metabolic syndrome. Clin Nutr,1999,18:353-358.
  • 6Kumar KS,Malet PF. Nonalcoholic steatohepatitis. Mayo Clin Proc,2000,75(7):733-739.
  • 7Marchesini G,Brizi M,Morselli-Labate AM,et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med,1999,107(5):450-455.
  • 8Luyckx FH,Lefebvre PJ,Scheen AJ. Nonalcoholic steatohepatitis:association with obesity and insulin resistance,and influence of weight loss. Diabetes Metab,2000,26:98-106.
  • 9Pares A,Tresserras R,Nunez I,et al. Prevalence and factors associated to the presence of fatty liver in apparently health adult men. Med-Clin-Barc,2000,114:561-565.

同被引文献10

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部